Add BrightSurf on Google Email

Science News for February 25, 2002


Rutgers researcher develops new UV technology

A new method for producing ultraviolet (UV) light has been patented by Rutgers researchers, providing a more energy-efficient source with higher power and lower maintenance. The technology has broad industrial and commercial applications in the semiconductor, printing, and lighting industries.

SourceRutgers University·DateFeb 25, 2002

Effective treatment for children with ADHD and chronic tic disorders

A new study published in Neurology has demonstrated that the combination of clonidine and methylphenidate (Ritalin) is an effective treatment for children with ADHD and chronic tic disorders, with minimal side effects. The treatment was found to improve 'on task' behavior and attentiveness, while reducing symptoms of crying, frustratio...

SourceAmerican Academy of Neurology·JournalNeurology·DateFeb 25, 2002

New treatment options for children with ADHD

A new study found that methylphenidate (MPH) is effective in treating children with both attention deficit hyperactivity disorder (ADHD) and tic disorders like Tourette's. The treatment was previously thought to worsen tics, but the study showed no increase in tics and even eased them in some cases.

SourceUniversity of Rochester Medical Center·JournalNeurology·DateFeb 25, 2002
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

Homing in on a receptor for the fifth taste

Researchers have identified a receptor for the fifth taste, amino acid, which may aid understanding of how animals regulate nutritional intake. The discovery also has potential applications in the food industry, such as formulating new products with specific tastes.

SourceHoward Hughes Medical Institute·JournalNature·DateFeb 25, 2002

UT Southwestern study links asthma and pneumonia

A UT Southwestern study has found a link between Mycoplasma pneumoniae bacteria and asthma, suggesting that lingering infections may cause chronic respiratory issues. The research suggests that treating acute M. pneumoniae infections could help prevent later development of asthma.

SourceUT Southwestern Medical Center·JournalInfection and Immunity·DateFeb 25, 2002
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Hebrew University research finds why chemotherapy might lead to cancer

A study by Prof. Kerem and Asaf Hellman found that chemotherapy drugs can cause chromosomes to break at specific regions, known as fragile sites, potentially leading to cancer growth. The research creates a better understanding of how cancer drugs work, paving the way for more effective treatments.

SourceThe Hebrew University of Jerusalem·JournalCancer Cell·DateFeb 25, 2002
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Gene linked to accelerated brain aging in healthy adults

Researchers at Duke University Medical Center found a link between nerve cell changes and the apolipoprotein E4 gene. Those with the APOE4 gene experienced more rapid loss of nerve cell functioning, leading to accelerated brain aging. This study may lead to new understanding of age-related memory loss and potentially sharper brains.

SourceDuke University Medical Center·DateFeb 25, 2002

'Smart' methods for detecting computer network intruders

The researchers report that the rough sets method offers significant advantages in intrusion detection, including the ability to work with missing values and imprecise data. The team's study found an average classification accuracy rate of 75.68% for rough sets, compared to 69.78% for neural nets and 51.16% for inductive learning.

SourcePenn State·JournalDecision Sciences·DateFeb 25, 2002
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Aventis Pasteur statement on HVTN 501 decision

The Aventis Pasteur statement emphasizes the continued development of its ALVAC vector as a preventive AIDS vaccine. The company remains committed to multiple trials using ALVAC-HIV (vCP1452) and supports research into its therapeutic potential, with ongoing phase I/II studies underway.

SourceCooney Waters Group, Inc.·DateFeb 25, 2002